AVENUE THERAPEUTICS INC (ATXI) Stock Price, Quote & AI Analysis
Live ATXI stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for AVENUE THERAPEUTICS INC.
TradeVae provides AI-driven analysis and real-time market intelligence for AVENUE THERAPEUTICS INC (ATXI), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.
AI Analysis
Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.
Generating AI analysis...
AVENUE THERAPEUTICS INC's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.
AVENUE THERAPEUTICS INC Overview
Company information
Company Overview
Avenue Therapeutics, Inc. is a specialty pharmaceutical company, which engages in acquiring, licensing, and commercializing products for use in the intensive care hospital setting. It focuses on the development of intravenous tramadol, a potential alternative that could reduce the use of conventional opioids for patients suffering from acute pain. The company was founded on February 9, 2015 and is headquartered in New York, NY.
Company Details
Technical Indicators
Key technical analysis metrics and signals
Loading technical indicators...
Valuation Metrics
Key valuation ratios and comparisons
Loading valuation metrics...
AVENUE THERAPEUTICS INC Earnings & Financial Statements
Earnings Calendar
Upcoming earnings dates and historical surprises
Loading earnings calendar...
Financial Statements
Income statements, balance sheets, and cash flow
Loading income statements...
Loading balance sheets...
Loading cash flow statements...